Company / CapEx per Share
GYRE THERAPEUTICS, INC. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.01 / $0.08
FY2021-FY2025
Trend
-54.4%
vs FY2024
Sector context
#115 of 192
Health Care
What the data says
At $0.01, GYRE THERAPEUTICS, INC.'s capex per share ranks #115 of 192 in the Health Care sector. Declined from $0.08 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2025 with a 3-year CAGR of -40.6%.
Declined from $0.08 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -40.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#115 of 192 in Health CareTop 60% of 192This company $0.01 Sector average $2.46
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 54.4% year-over-year.
- Ranks #115 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2016.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -54.4% |
| FY2024 | $0.03 | -61.4% |
| FY2023 | $0.08 | +19.0% |
| FY2022 | $0.07 | +73.5% |
| FY2021 | $0.04 | - |
| FY2020 | - | - |
| FY2019 | $0.01 | +41.6% |
| FY2018 | $0.00 | -43.7% |
| FY2017 | $0.01 | -98.9% |
| FY2016 | $0.60 | -34.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026